TD Cowen Reiterates Hold Rating on Theravance Biopharma (TBPH)
Tweet Send to a Friend
TD Cowen analyst Marc Frahm reiterated a Hold rating and $10.00 price target on Theravance Biopharma (NASDAQ: TBPH).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
